Assess execution risk
Review factors such as protocol complexity, enrollment feasibility, site readiness and data management in a consistent assessment.
oPoS: Clinical Trial Risk Navigator · A BleuConsult product
Clinical trial operational risk assessment before you commit.
oPoS helps biotech founders and clinical operations teams structure a review of protocol execution risk across the 14 Killer Factors. Identify priorities for a qualified human to review before study startup, vendor decisions or your next planning discussion.
Calculator access requires sign-in. Premium features remain subject to your existing access level.
Turn operational concerns into a structured review
Prioritize follow-up
Use the risk score, risk band and recommendations to frame questions, identify gaps and support planning discussions.
Keep human judgment in control
Review assumptions and recommendations with qualified stakeholders. Existing premium consistency checks support review; they do not replace approval.
Who is oPoS for?
Early biotech teams, sponsor-side clinical operations leads and founders preparing for study startup or reviewing execution plans. Bring your operational assumptions and use the assessment to guide a focused risk discussion.
Is oPoS a probability-of-success prediction?
oPoS provides a structured operational risk score. It does not establish the probability of clinical efficacy, regulatory approval or commercial success. Scores and impact estimates are advisory and depend on the information and assumptions entered.
How do BleuConsult and oPoS fit together?
BleuConsult is the clinical operations advisory company. oPoS is its clinical trial risk assessment product. Teams can use the product alongside a BleuConsult consult to discuss operational priorities and next steps.
What can I review before signing in?
Explore pricing, published framework governance, and BleuConsult services. The calculator is accessed separately through sign-in.
